Tysabri

Tysabri Contraindications

natalizumab

Manufacturer:

Eisai

Distributor:

Zuellig Pharma
Full Prescribing Info
Contraindications
Hypersensitivity to natalizumab or to any of the excipients listed in Description.
Progressive multifocal leukoencephalopathy (PML).
Patients with increased risk for opportunistic infections, including immunocompromised patients [including those currently receiving immunosuppressive therapies or those immunocompromised by prior therapies, (see Precautions and Adverse Reactions)].
Combination with other DMTs.
Known active malignancies, except for patients with cutaneous basal cell carcinoma.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in